% | $
Quotes you view appear here for quick access.

Cytori Therapeutics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • eyesandears51 eyesandears51 Dec 14, 2012 1:24 PM Flag

    CYTX: Here's My Take


    I understand and feel your frustration. Creating value for shareholders, now is all about management meeting partnership, commercial, clinical, and cash management milestones. It is important that stockholders proactively hold management accountable for articulating very specific Q by Q 2013 milestones in each of these four areas. The Board of Directors should set management compensation (quarterly bonus and stock compensation) exclusively on meeting these specific targets. I recently had the privilege to serve shareholders, as CEO, for 13 years of a Silicon Valley company, and had very real experience with setting Board approved targets that were paid out quarterly. The Board Members had 100%, CEO 70%, Officers 50%, management director levels 30%, and everyone else 15-25% ( based on level ), of total compensation " at risk " based on milestone attainment. This focused all levels of management on meeting very specific and measurable value creating targets, and was the primary content in the operations section of the Board meetings. Those members of the management team who failed to perform usually elected to leave because the " fixed " compensation was inadequate to support their lifestyles if the " at risk " portion could not be realized. Net effect, close alignment between shareholder interests and management/team members. I suggest, if you concur, communicating directly to the Board of Directors our expectation that the Compensation Discussion and Analysis section of the 10K be guided by achieving this alignment of interests

0.6601-0.0208(-3.05%)May 22 4:00 PMEDT